dc.contributor.author |
Vreeman, Rachel C |
|
dc.contributor.author |
Rakhmanina, Natella Y |
|
dc.contributor.author |
Nyandiko, Winstone M |
|
dc.contributor.author |
Puthanakit, Thanyawee |
|
dc.contributor.author |
Kantor, Rami |
|
dc.date.accessioned |
2022-09-28T12:34:47Z |
|
dc.date.available |
2022-09-28T12:34:47Z |
|
dc.date.issued |
2021-06-07 |
|
dc.identifier.uri |
doi.org/10.1002/jia2.25759 |
|
dc.identifier.uri |
http://ir.mu.ac.ke:8080/jspui/handle/123456789/6809 |
|
dc.description.abstract |
Forty years ago, the first adult HIV cases were published, with infant cases following within a year [1]. As a few of these then‐babies approach their 40th birthdays, both their growth and science’s growth tell dramatic stories. Antiretroviral therapy (ART) transformed HIV from a deadly infection into a chronic disease. Just as miraculous, an AIDS‐free generation became imaginable, using ART to prevent >95% of perinatal transmission. While these advances in HIV prevention and treatment deserve celebration, attention should be devoted to remaining hurdles – such as behavioural, social viral suppression and drug resistance challenges – that must still be overcome to ensure successful life‐long outcomes for the global population of children and adolescents who have grown up with HIV (CAWH) |
en_US |
dc.description.sponsorship |
NIH R01 AI147333 and R01 AI120792 |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
PubMed Central |
en_US |
dc.subject |
Adult HIV |
en_US |
dc.subject |
40 years of successes and challenges |
en_US |
dc.title |
Are we there yet? 40 years of successes and challenges for children and adolescents living with HIV |
en_US |
dc.type |
Article |
en_US |